FSD Pharma says court of appeal dismisses motion for leave to appeal

FSD Pharma announced that the Court of Appeal for Ontario affirmed the Judgment entered by the Superior Court of Justice in the amount of CDN $2.81 million, plus $175,000, plus interest. An additional $5,000 in costs were awarded to FSD Pharma by the Court of Appeal in respect of Dr. Raza Bokhari’s failed motion for leave to appeal. The Judgment confirmed Arbitration Awards in which the Arbitrator dismissed Dr. Raza Bokhari’s claims for wrongful dismissal, and awarded FSD Pharma its fees and costs incurred in defending the arbitration. In December 2023, FSD Pharma filed a Petition to Confirm Arbitration Awards in the United States District Court for the Eastern District of Pennsylvania. This begins the process by which FSD Pharma will collect from Dr. Raza Bokhari the amounts awarded by the Arbitrator.